医学
放射外科
前庭神经鞘瘤
无线电技术
接收机工作特性
磁共振成像
回顾性队列研究
前庭系统
队列
放射科
核医学
内科学
放射治疗
作者
Patrick Langenhuizen,Svetlana Zinger,Sieger Leenstra,Henricus P. M. Kunst,Jef J. S. Mulder,Patrick E. J. Hanssens,Peter H. N. de With,Jeroen B. Verheul
出处
期刊:Otology & Neurotology
[Ovid Technologies (Wolters Kluwer)]
日期:2020-11-09
卷期号:41 (10): e1321-e1327
被引量:20
标识
DOI:10.1097/mao.0000000000002886
摘要
Stereotactic radiosurgery (SRS) is one of the treatment modalities for vestibular schwannomas (VSs). However, tumor progression can still occur after treatment. Currently, it remains unknown how to predict long-term SRS treatment outcome. This study investigates possible magnetic resonance imaging (MRI)-based predictors of long-term tumor control following SRS.Retrospective cohort study.Tertiary referral center.Analysis was performed on a database containing 735 patients with unilateral VS, treated with SRS between June 2002 and December 2014. Using strict volumetric criteria for long-term tumor control and tumor progression, a total of 85 patients were included for tumor texture analysis.All patients underwent SRS and had at least 2 years of follow-up.Quantitative tumor texture features were extracted from conventional MRI scans. These features were supplied to a machine learning stage to train prediction models. Prediction accuracy, sensitivity, specificity, and area under the receiver operating curve (AUC) are evaluated.Gray-level co-occurrence matrices, which capture statistics from specific MRI tumor texture features, obtained the best prediction scores: 0.77 accuracy, 0.71 sensitivity, 0.83 specificity, and 0.93 AUC. These prediction scores further improved to 0.83, 0.83, 0.82, and 0.99, respectively, for tumors larger than 5 cm.Results of this study show the feasibility of predicting the long-term SRS treatment response of VS tumors on an individual basis, using MRI-based tumor texture features. These results can be exploited for further research into creating a clinical decision support system, facilitating physicians, and patients to select a personalized optimal treatment strategy.
科研通智能强力驱动
Strongly Powered by AbleSci AI